These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


375 related items for PubMed ID: 15729367

  • 1. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
    Oosterhoff D, Pinedo HM, Witlox MA, Carette JE, Gerritsen WR, van Beusechem VW.
    Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
    [Abstract] [Full Text] [Related]

  • 2. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 3. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A, Abate-Daga D, Garcia-Rodríguez L, González JR, Alemany R, Fillat C.
    Gene Ther; 2007 Oct 15; 14(20):1471-80. PubMed ID: 17713568
    [Abstract] [Full Text] [Related]

  • 4. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
    Wildner O, Morris JC.
    J Gene Med; 2000 Oct 15; 2(5):353-60. PubMed ID: 11045429
    [Abstract] [Full Text] [Related]

  • 5. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus.
    Raki M, Hakkarainen T, Bauerschmitz GJ, Särkioja M, Desmond RA, Kanerva A, Hemminki A.
    Gene Ther; 2007 Oct 15; 14(19):1380-8. PubMed ID: 17611584
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
    van Beusechem VW, van den Doel PB, Grill J, Pinedo HM, Gerritsen WR.
    Cancer Res; 2002 Nov 01; 62(21):6165-71. PubMed ID: 12414643
    [Abstract] [Full Text] [Related]

  • 10. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
    Ibrišimović M, Nagl U, Kneidinger D, Rauch M, Lion T, Klein R.
    J Gene Med; 2012 Jan 01; 14(1):3-19. PubMed ID: 22190534
    [Abstract] [Full Text] [Related]

  • 11. Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase.
    Oh JY, Park MY, Kim DR, Lee JH, Shim SH, Chung JH, Yoon HI, Lee JH, Sung MW, Kim YS, Lee CT.
    Int J Mol Med; 2010 Mar 01; 25(3):369-76. PubMed ID: 20127041
    [Abstract] [Full Text] [Related]

  • 12. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Rein DT, Breidenbach M, Kirby TO, Han T, Siegal GP, Bauerschmitz GJ, Wang M, Nettelbeck DM, Tsuruta Y, Yamamoto M, Dall P, Hemminki A, Curiel DT.
    Clin Cancer Res; 2005 Feb 01; 11(3):1327-35. PubMed ID: 15709205
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
    Palmer DH, Chen MJ, Searle PF, Kerr DJ, Young LS.
    Gene Ther; 2005 Aug 01; 12(15):1187-97. PubMed ID: 15800660
    [Abstract] [Full Text] [Related]

  • 14. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T, Wahlfors T, Meriläinen O, Loimas S, Hemminki A, Wahlfors J.
    J Gene Med; 2005 Jul 01; 7(7):898-907. PubMed ID: 15759279
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.